| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |